ES8600055A1 - A procedure for co-encapsulating a liposome-drug preparation in lipid vesicles - Google Patents

A procedure for co-encapsulating a liposome-drug preparation in lipid vesicles

Info

Publication number
ES8600055A1
ES8600055A1 ES534756A ES534756A ES8600055A1 ES 8600055 A1 ES8600055 A1 ES 8600055A1 ES 534756 A ES534756 A ES 534756A ES 534756 A ES534756 A ES 534756A ES 8600055 A1 ES8600055 A1 ES 8600055A1
Authority
ES
Spain
Prior art keywords
liposome
encapsulating
procedure
lipid vesicles
drug preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES534756A
Other languages
Spanish (es)
Other versions
ES534756A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elan Pharmaceuticals LLC
Original Assignee
Liposome Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liposome Co Inc filed Critical Liposome Co Inc
Publication of ES8600055A1 publication Critical patent/ES8600055A1/en
Publication of ES534756A0 publication Critical patent/ES534756A0/en
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to the preparation of mixtures of antimicrobial agents encapsulated together in liposomes, which when administered in vivo have an enhanced therapeutic effect. The therapeutic efficacy of the antimicrobial agents encapsulated together is greater than that of the same combination administered in solution or in the form of a mixture of liposome populations which each contain one of the antimicrobial agents.
ES534756A 1983-08-01 1984-07-31 A PROCEDURE FOR COENCAPSULATING IN LIPID VESICLES A PREPARATION OF LIPOSOMA-PHARMACY. Granted ES534756A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51891283A 1983-08-01 1983-08-01

Publications (2)

Publication Number Publication Date
ES8600055A1 true ES8600055A1 (en) 1985-10-01
ES534756A0 ES534756A0 (en) 1985-10-01

Family

ID=24066005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534756A Granted ES534756A0 (en) 1983-08-01 1984-07-31 A PROCEDURE FOR COENCAPSULATING IN LIPID VESICLES A PREPARATION OF LIPOSOMA-PHARMACY.

Country Status (3)

Country Link
ES (1) ES534756A0 (en)
GR (1) GR82333B (en)
ZA (1) ZA845950B (en)

Also Published As

Publication number Publication date
ZA845950B (en) 1985-03-27
GR82333B (en) 1984-12-13
ES534756A0 (en) 1985-10-01

Similar Documents

Publication Publication Date Title
ES8603264A1 (en) Enhancement of antimicrobial activity by incorporating mixture of antimicrobial agents into lipid vesicles.
GR1000074B (en) Lipoid vesicula for endoperitoneal supplying of therapeutical elements
EP0465588A4 (en) The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
EP0219922A3 (en) Anthracycline antineoplastic agents encapsulated in phospholipid micellular particles
GB8407325D0 (en) Preparing lipid vesicles
HK135793A (en) Liposomes from synthetic lipids
EP0406998A3 (en) Use of phospholipids in lung surfactant replacement therapy
DE69332276T2 (en) Liposomes COMPOSITION
AU3762595A (en) Ether lipid liposomes and their therapeutic use
GR3034777T3 (en) Biphasic multilamellar lipid vesicles
EP0461559A3 (en) Non active substance containing liposomes for the treatment of atherosclerosis
ES8600055A1 (en) A procedure for co-encapsulating a liposome-drug preparation in lipid vesicles
ES2071995T3 (en) COMPOSITION FOR MACROPHAGY ACTIVATION.
GB2188900B (en) Fusogenic phospholipid vesicles.
DK0397542T3 (en) Stabilization procedure for hydrated lamellar phases
MX9304133A (en) NEW DERIVATIVES OF PHOSPHOLIPIDS.
GR3017020T3 (en) Liposomal compositions.
ES534885A0 (en) PROCEDURE FOR THE PREPARATION OF LIPOSOMES
HK32192A (en) Enhancement of antimicrobial activity by incorporating mixture of antimicrobial agents into lipid vesicles
IL80698A0 (en) Preparation of unilamellar liposomes and pharmaceutical compositions containing them
IL80698A (en) Preparation of unilamellar liposomes and pharmaceutical compositions containing them
IE881028L (en) Liposomal vesicles for intraperitoneal administration of¹therapeutic agents
GB8325357D0 (en) Preparation/isolation of 2-stilbylnaphthtriazole fluorescent whitening agents
IT8947669A0 (en) PHOSPHOLIPID LIPOSOMES CONTAINING ACTIVE INGREDIENTS AND PROCEDURE FOR THEIR PRODUCTION